Advertisement

Reactions Weekly

, Volume 1766, Issue 1, pp 288–288 | Cite as

Vancomycin

Cholecystitis due to a recurrence of methicillin resistant Staphylococcus aureus bacteraemia: case report
Case report

A 67-year-old woman developed cholecystitis due to a recurrence of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia following treatment with vancomycin for MRSA associated with nosocomial pneumonia.

The woman presented to the emergency room (current presentation) with malaise and abdominal pain for 3 days. She reported right mid-quadrant pain with chills, multiple episodes of non-bilious emesis and occasional nausea. She had history of hypertension, end-stage renal disease (ESRD) on haemodialysis, diet controlled diabetes and hyperlipidaemia. She had undergone arteriovenous (AV) fistula creation. Six months prior to the current presentation, she was hospitalised due to MRSA bacteraemia associated with nosocomial pneumonia. At that time, the pathogen's minimum inhibitory concentration (MIC) for vancomycin was 2 mg/L. Therefore, she was treated with IV vancomycin [dosage not stated] for 2 weeks during dialysis and maintained at therapeutic levels, which had resulted in...

Reference

  1. Martin J, et al. Treatment considerations for recurrent MRSA bacteremia leading to cholecystitis. Journal of General Internal Medicine 26: 669-672, No. 6, Jun 2011. Available from: URL: http://doi.org/10.1007/s11606-011-1634-8 -USA

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations